EUVIMEDEUVIMED entdecken
Crossref

Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance

Nicholas Mikolajewicz, Kui Zhai, Anish Puri, Petar Miletic, Nazanin Tatari, Jiarun Wei, Neil Savage, Zhi Huang, Qian Huang, Seon Yong Lee, Mahta Jan-Ahmadnejad, Roseanne Nguyen und 16 weitere

Neuron · 2026-01 · 114 (2) · 237-249.e10

DOI: 10.1016/j.neuron.2025.12.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2026-01. Verfasst von Nicholas Mikolajewicz und 27 weiteren Autor:innen. Beteiligte Einrichtung: Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Receptors, CCR5, Chemokine CCL5, Neoplastic Stem Cells, Glioblastoma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) evolves within a microenvironment abundant in oligodendrocyte-lineage (OL) cells. In this study, we utilized single-cell and spatial transcriptomics from primary and recurrent GBM tumors, immunohistochemistry, cytokine profiling, and migration assays to show that GBM cells recruit OLs to the tumor border via fractalkine (i.e., CX3CL1/CX3CR1) signaling. A pan-disease human OL meta-atlas and syngeneic mouse models reveal an interferon (IFN)-induced reactive OL state, akin to those seen in demyelinating inflammatory and traumatic injury, which is enriched in central nervous system malignancies. These reactive OLs secrete pro-tumorigenic cytokines, notably C-C motif chemokine ligand 5 (CCL5), that promote GBM tumor cell growth through C-C chemokine receptor type 5 (CCR5) signaling. CCR5 is preferentially expressed in glioma stem-like cells (GSCs) and upregulated at recurrence. Targeting CCR5 with genetic knockdown or the approved drug maraviroc impairs GSC stemness and prolongs survival in GBM models. Our work highlights the functional interplay between OLs and GBM cells and positions the CCL5/CCR5 axis as a druggable target in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR5Chemokine CCL5Neoplastic Stem CellsGlioblastomaBrain NeoplasmsOligodendrogliaHumansAnimalsMiceDisease ProgressionCell Line, TumorSignal Transduction

Stichwörter der Autor:innen

CCL5CCR5CX3CL1CX3CR1glioblastomaglioma stem cellsmaravirocoligodendrocyte progenitor cellsoligodendrocytessingle-cell transcriptomics

Substanzen

Receptors, CCR5Chemokine CCL5CCL5 protein, humanCCR5 protein, human

Autor:innen und Institutionen

  • Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
  • Centre for Discovery in Cancer Research (CDCR), McMaster University, Hamilton, ON, Canada; Department of Surgery, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
  • Centre for Discovery in Cancer Research (CDCR), McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
  • Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Program for Developmental, Stem Cell and Cancer Biology, Program for Neurosciences and Mental Health, The Hospital for Sick Children, Toronto…

Förderung

  • CIHR

Zitieren

APA

Mikolajewicz, N., Zhai, K., Puri, A., Miletic, P., Tatari, N., Wei, J., Savage, N., Huang, Z., Huang, Q., Lee, S. Y., Jan-Ahmadnejad, M., Nguyen, R., Chen, D., Korman, T., Mobilio, D., Topley, M., Lu, J. Q., Voisin, M. R., Zador, Z., …, & Moffat, J. (2026). Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance. Neuron, 114(2), 237-249.e10. https://doi.org/10.1016/j.neuron.2025.12.012

Vancouver

Mikolajewicz N, Zhai K, Puri A, Miletic P, Tatari N, Wei J, et al. Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance. Neuron. 2026;114(2):237-249.e10. doi:10.1016/j.neuron.2025.12.012

BibTeX
@article{Mikolajewicz2026,
  author = {Mikolajewicz, Nicholas and Zhai, Kui and Puri, Anish and Miletic, Petar and Tatari, Nazanin and Wei, Jiarun and Savage, Neil and Huang, Zhi and Huang, Qian and Lee, Seon Yong and Jan-Ahmadnejad, Mahta and Nguyen, Roseanne and Chen, David and Korman, Tiegan and Mobilio, Daniel and Topley, Maxwell and Lu, Jack Qinyu and Voisin, Matthew R and Zador, Zsolt and Chafe, Shawn C and Venugopal, Chitra and Brown, Kevin R and Zadeh, Gelareh and Han, Hong and Muffat, Julien and Bao, Shideng and Singh, Sheila K and Moffat, Jason},
  title = {Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance},
  journal = {Neuron},
  year = {2026},
  volume = {114},
  number = {2},
  pages = {237--249.e10},
  doi = {10.1016/j.neuron.2025.12.012}
}
Kostenlos starten →